# Hypofractionated Post-prostatectomy Radiotherapy (HYPORT)for Localized Prostate Cancer

> **NCT06325995** · NA · RECRUITING · sponsor: **Changhai Hospital** · enrollment: 428 (estimated)

## Conditions studied

- Localized Prostate Cancer

## Interventions

- **RADIATION:** Conventional radiation therapy
- **RADIATION:** Hypofractionated radiation therapy

## Key facts

- **NCT ID:** NCT06325995
- **Lead sponsor:** Changhai Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-01
- **Primary completion:** 2026-02-01
- **Final completion:** 2031-02-01
- **Target enrollment:** 428 (ESTIMATED)
- **Last updated:** 2024-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06325995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06325995, "Hypofractionated Post-prostatectomy Radiotherapy (HYPORT)for Localized Prostate Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06325995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*